Recent Articles from GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Kyndryl Holdings, Inc. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action First Filed by the Firm – KD
NEW YORK, April 05, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 5, 2026
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Power Solutions International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PSIX
NEW YORK, April 05, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 5, 2026
ROSEN, THE FIRST FILING FIRM, Encourages Apollo Global Management, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - APO
NEW YORK, April 05, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 5, 2026
HUBG Investor News: If You Have Suffered Losses in Hub Group, Inc. (NASDAQ: HUBG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ODDITY Tech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ODD
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
ROSEN, SKILLED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
ROSEN, THE FIRST FILING FIRM, Encourages Franklin BSP Realty Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FBRT
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Snowflake Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNOW
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DRVN
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 4, 2026
PSIX INVESTOR REMINDER: Power Solutions International Inc. Investors Have Until May 19, 2026 To Seek Lead Plaintiff Role – Contact Kirby McInerney LLP
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP has filed a class action lawsuit, Dishion v. Power Solutions International Inc. et al., No. 26 Civ. 3149, in the United States District Court for the Northern District of Illinois on behalf of investors who acquired Power Solutions International Inc. (“Power Solutions” or the “Company”) (NASDAQ:PSIX) securities. If you purchased or otherwise acquired securities, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · April 3, 2026
ATRA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Atara Biotherapeutics, Inc. Investors - Contact Kirby McInerney LLP by May 22, 2026
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ:ATRA) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · April 3, 2026
Vireo Growth Inc. Partners with Ace Ventures to Establish New York’s First Minority-owned Vertically Integrated Medical Cannabis Operator
Majority ownership of Vireo Health of New York to transfer to MWBE-led Ace Ventures; partnership reinforces long-term alignment with New York’s social equity framework
By Vireo Growth Inc. · Via GlobeNewswire · April 3, 2026
H2 Water Technologies Ltd. Announces Issuance of Key U.S. Patent for Producing Hydrogen Rich Water; Identifies Echo Water's “Hydrogen Prebiotic Stick” as Infringing Product
VANCOUVER, British Columbia, April 03, 2026 (GLOBE NEWSWIRE) -- H2 Water Technologies Ltd., a leading innovator in hydrogen water research and technology, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,588,693, titled ”Composition for Producing Hydrogen Rich Water." This newly issued patent adds to H2 Water Technologies' broad intellectual property portfolio and protects an important technology for health-minded consumers.
By H2 Water Technologies Ltd · Via GlobeNewswire · April 3, 2026
DRVN INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Driven Brands Holdings Inc. Investors
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Driven Brands Holdings Inc. (“Driven Brands” or the “Company”) (NASDAQ:DRVN) investors of the May 8, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Driven Brands securities between May 9, 2023 through February 24, 2026 (“the Class Period”).
By Kirby McInerney LLP · Via GlobeNewswire · April 3, 2026
COTY SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Coty Inc. Investors - Contact Kirby McInerney LLP by May 22, 2026
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Coty Inc. (“Coty” or the “Company”) (NYSE:COTY) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · April 3, 2026
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years and Section 1003(a)(iii) of the Company Guide requiring a company to have stockholders’ equity of at least $6.0 million if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years. As of December 31, 2025, the Company had stockholders’ equity of $4.83 million and has had losses in the most recent five fiscal years ended December 31, 2025. The Notice also indicates that the Company is not currently eligible for any exemption in Section 1003(a) of the Company Guide.
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on April 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,138 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee’s acceptance of employment with Anika as a component of the grantee’s employment compensation.
By Anika Therapeutics Inc. · Via GlobeNewswire · April 3, 2026
Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders
LAS VEGAS, NEVADA., April 03, 2026 (GLOBE NEWSWIRE) -- Jena Acquisition Corporation II (the “Company”) announced today that on April 1, 2026, the Company received a written notice from the staff of NYSE Regulation of the New York Stock Exchange (“NYSE”) indicating that the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Listing Rule”) which requires the Company to maintain a minimum of 300 public stockholders on a continuous basis.
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on April 1, 2026 (the “Grant Date”), ORIC granted a total of 80,000 non-qualified stock options and 15,000 restricted stock units to one new non-executive employee who began their employment with ORIC in March 2026.
By ORIC Pharmaceuticals · Via GlobeNewswire · April 3, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, effective April 1, 2026, the company granted non-qualified stock options to purchase 3,257 shares of its common stock to two new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan.
By Xilio Therapeutics, Inc. · Via GlobeNewswire · April 3, 2026
Arhaus Expands in Northern Virginia with New Ashburn Showroom
The artisan-crafted furnishings brand deepens its roots in Northern Virginia with a new showroom opening at One Loudoun
By Arhaus, Inc. · Via GlobeNewswire · April 3, 2026
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on April 1, 2026, the Company granted inducement awards to purchase up to 228,500 shares of common stock to eight new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.
By Syndax Pharmaceuticals, Inc. · Via GlobeNewswire · April 3, 2026
First Hawaiian to Report First Quarter 2026 Financial Results on April 24, 2026
HONOLULU, April 03, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its first quarter 2026 financial results on Friday, April 24, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time).
By First Hawaiian, Inc. · Via GlobeNewswire · April 3, 2026
ClimateTech Connect Announces Global Pitch Competition Finalists Ahead of Next Week's Conference
Six Climate Risk Innovation Startups to Compete on the Main Stage at the April 8-9 Event in Washington, D.C.
By ClimateTech Connect · Via GlobeNewswire · April 3, 2026
8th Annual Evening to Remember Benefit for Camp Southern Ground Features Zac Brown Band
The Benefit Raised a Record-breaking $3.4 Million to Support Children, Veterans, and Military Families
By Camp Southern Ground · Via GlobeNewswire · April 3, 2026
GROCERY OUTLET INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Grocery Outlet Holding Corp. (NASDAQ:GO) Investors that a Class Action Lawsuit Has Been Filed and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Grocery Outlet (GO) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 3, 2026
DBM Global to Pay Cash Dividend
PHOENIX, April 03, 2026 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE: VATE), announced today that it will pay a cash dividend of approximately $3 million, or $0.78 per share, on April 28, 2026 to DBMG’s stockholders of record at the close of business on April 13, 2026.
By DBM Global Inc. · Via GlobeNewswire · April 3, 2026
Weight Watchers Announces Leadership Transition and Board Updates
Office of the CEO Established to Oversee Business Operations 
By WW International Inc. · Via GlobeNewswire · April 3, 2026
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PayPal and REGENXBIO and Encourages Investors to Contact the Firm
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of PayPal Holdings, Inc. (NASDAQ:PYPL) and REGENXBIO Inc. (NASDAQ:RGNX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · April 3, 2026
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WILMINGTON, Del., April 03, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an aggregate of 685,718 shares of the Company’s common stock to five newly-hired non-executive employees under the Company’s 2026 Inducement Equity Plan (the “Inducement Plan”), effective as of March 31, 2026 (the “Effective Date”). The inducement grants were previously approved by the Compensation Committee of the Company’s Board of Directors, as a material inducement to the new employees’ entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).The options have an exercise price of $1.68 per share, which is equal to the closing price of the Company’s common stock on the Effective Date. The options have a ten year term, with 25% vesting on the first anniversary of the Effective Date and the remaining 75% vesting in 36 equal monthly installments thereafter. The options are subject to the terms and conditions of the Inducement Plan approved by the Company’s Board of Directors in March 2026 and the terms and conditions of award agreements covering the grants.
By Inhibikase Therapeutics · Via GlobeNewswire · April 3, 2026
Bragar Eagel & Squire, P.C. Urges Ostin and NuScale Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ostin Technology Group Co., Ltd. (NASDAQ:OST) and NuScale Power Corporation (NYSE:SMR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · April 3, 2026
Aaron Thomas crowned winner of the 7th Superyacht Chef Competition at the Yacht Club de Monaco
MONACO, April 03, 2026 (GLOBE NEWSWIRE) -- Aaron Thomas is the winner of the 7th Superyacht Chef Competition. Organized by the Yacht Club de Monaco’s training center, La Belle Classe Academy, in partnership with Bluewater, the event featured a top-level jury chaired by two-Michelin-star French chef Philippe Etchebest. He was joined by chef Carlo Cracco, an icon of Italian cuisine; three-Michelin-star chef Marcel Ravin; Jeeny Maltese, a presenter promoting Latin American cuisine; and restaurateur and TV presenter Tim Mälzer.
By Yacht Club de Monaco · Via GlobeNewswire · April 3, 2026
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
SOUTH SAN FRANCISCO, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it has received notification from Takeda of its decision to terminate the collaboration agreement between the two companies to co-develop and co-commercialize DNL593 (PTV:PGRN). The decision was driven by strategic considerations and is not related to efficacy or safety data. DNL593 is an investigational progranulin replacement therapy utilizing Denali’s Protein TransportVehicle™ (PTV) to deliver progranulin across the blood-brain barrier to the brain for the treatment of frontotemporal dementia-granulin (FTD-GRN). Denali has led development activities and will regain full control of DNL593 and its intellectual property portfolio.
By Denali Therapeutics Inc. · Via GlobeNewswire · April 3, 2026
BLACKROCK TCP DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urgently Reminds BlackRock TCP Investors with Large Losses to Contact the Firm Before April 6th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BlackRock TCP (TCPC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 3, 2026
MoneyFlare Launches the Best AI Crypto Trading App Supporting One-Click Quantitative Trading
MoneyFlare, a leading AI-powered crypto trading platform, has officially launched its highly anticipated AI Crypto Trading App, designed to revolutionize the way crypto enthusiasts trade. This app allows users to start quantitative trading with a single click, offering a seamless and efficient solution for both beginners and experienced traders alike.
By Money Flare · Via GlobeNewswire · April 3, 2026
Alterra IOS Acquires 5 Industrial Outdoor Storage Locations in Central Florida
Strategic investments in Orlando and Tampa increase the firm’s Central Florida footprint to 35 properties spanning 145.2 usable acres
By Alterra IOS · Via GlobeNewswire · April 3, 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 and November 4, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2026 lead plaintiff deadline.
By The Rosen Law Firm PA · Via GlobeNewswire · April 3, 2026
King Willem-Alexander and Queen Máxima to pay working visit to Pennsylvania, Washington, D.C., and Florida
Washington, D.C., April 03, 2026 (GLOBE NEWSWIRE) -- His Majesty King Willem-Alexander and Her Majesty Queen Máxima will pay a working visit to the United States. The visit, which will take place from Monday 13 to Wednesday 15 April 2026, will cover Philadelphia (Pennsylvania), Washington, DC and Miami (Florida).
Global Virus Network Monitors SARS-CoV-2 Variant BA.3.2 (“Cicada”), Emphasizes No Cause for Alarm
Early findings show immune escape consistent with Omicron evolution, with no evidence of increased severity or widespread transmission
By Global Virus Network · Via GlobeNewswire · April 3, 2026
Former Sen. Sam Nunn Visits Ingalls Shipbuilding for Update on His Namesake Destroyer
PASCAGOULA, Miss., April 03, 2026 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Ingalls Shipbuilding division recently welcomed former U.S. Sen. Sam Nunn, his wife, Colleen Nunn, and their daughter and ship sponsor Michelle Nunn, for a visit to the shipyard. The visit included a construction update and tour of the future USS Sam Nunn (DDG 133), a Flight III Arleigh Burke-class destroyer named in honor of the senator, and marked their return to Ingalls following the ship’s keel authentication ceremony.
By HII · Via GlobeNewswire · April 3, 2026
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vital Farms, Inc. (“Vital Farms” or “the Company”) (NASDAQ: VITL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
Pope Leo XIV Advances Boys Town’s Father Edward Flanagan a Step Closer to Sainthood
Boys Town, Neb., April 03, 2026 (GLOBE NEWSWIRE) -- Boys Town received news that Pope Leo XIV approved the advancement of the beatification cause for Boys Town founder, Father Edward J. Flanagan, declaring him “Venerable.” Born in Ireland, Father Edward J. Flanagan arrived in the United States in 1904. Eight years later, he was ordained a priest and assigned to the Diocese of Omaha. In 1917, after years of working with Omaha's homeless men, he opened Father Flanagan's Boys Home, which later became Boys Town.
By Boys Town · Via GlobeNewswire · April 3, 2026
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Coty Inc. (“Coty” or “the Company”) (NYSE: COTY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
NUAI Investors Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against New Era Energy & Digital, Inc. (“New Era” or “the Company”) (NASDAQ: NUAI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lufax Holding Ltd (“Lufax” or “the Company”) (NYSE: LU) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (“ImmunityBio” or “the Company”) (NASDAQ: IBRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Super Micro Computer, Inc. (“Super Micro” or “the Company”) (NASDAQ: SMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hercules Capital, Inc. (“Hercules” or “the Company”) (NYSE: HTGC) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (NASDAQ: GOSS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
GEMI Investors Have Opportunity to Lead Gemini Space Station, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Gemini Space Station, Inc. (“Gemini” or “the Company”) (NASDAQ: GEMI) for violations of the federal securities laws.
By Schall Law · Via GlobeNewswire · April 3, 2026
PINS Investors Have Opportunity to Lead Pinterest, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
Bonaventure Completes Custom UPREIT Transaction at Attain Downtown East
ALEXANDRIA, Va., April 03, 2026 (GLOBE NEWSWIRE) -- Bonaventure, an operator-led multifamily real estate investment firm with approximately $2.8 billion in assets under management (AUM), is pleased to announce today the contribution of Attain Downtown East (fka Monticello Station) to Bonaventure Multifamily Income Trust (BMIT®), a non-traded real estate investment trust sponsored by Bonaventure. The acquisition was completed as an UPREIT transaction, which is a strategy where property owners contribute real estate to a REIT’s operating partnership, in exchange for ownership interest in that partnership. This transaction strategy allows owners to defer capital gains taxes on the sale of appreciated real estate while gaining access to a diversified portfolio managed by the REIT.
By Bonaventure · Via GlobeNewswire · April 3, 2026
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nektar Therapeutics (“Nektar” or “the Company”) (NASDAQ: NKTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
ALIT Investors Have Opportunity to Lead Alight, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alight, Inc. (“Alight” or “the Company”) (NYSE: ALIT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
IT Investors Have Opportunity to Lead Gartner, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gartner, Inc. (“Gartner” or “the Company”) (NYSE: IT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
PSIX Investors Have Opportunity to Lead Power Solutions International, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Power Solutions International, Inc. (“Power Solutions” or “the Company”) (NASDAQ: PSIX) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
CIGL Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Concorde International Group Ltd. (“Concorde” or “the Company”) (NASDAQ: CIGL) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
ODD Investors Have Opportunity to Lead Oddity Tech Ltd. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oddity Tech Ltd. (“Oddity” or “the Company”) (NASDAQ: ODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
MNDY Investors Have Opportunity to Lead monday.com Ltd. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against monday.com Ltd. (“monday.com” or “the Company”) (NASDAQ: MNDY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
CWH Investors Have Opportunity to Lead Camping World Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Camping World Holdings, Inc. (“Camping World” or “the Company”) (NYSE: CWH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
TCOM Investors Have Opportunity to Lead Trip.com Group Limited Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Trip.com Group Limited (“Trip.com” or “the Company”) (NASDAQ: TCOM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
DRVN Investors Have Opportunity to Lead Driven Brands Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Driven Brands Holdings Inc. (“Driven Brands” or “the Company”) (NASDAQ: DRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
EOSE Investors Have Opportunity to Lead Eos Energy Enterprises, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Eos Energy Enterprises, Inc. (“Eos Energy” or “the Company”) (NASDAQ: EOSE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. (“Soleno” or “the Company”) (NASDAQ: SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
APO Investors Have Opportunity to Lead Apollo Global Management, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apollo Global Management, Inc. (“Apollo” or “the Company”) (NYSE: APO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
ISG Strengthens West River Presence with ARC International in Rapid City
RAPID CITY, S.D., April 03, 2026 (GLOBE NEWSWIRE) -- ISG, a full-service architecture and engineering firm, has acquired ARC International, a Rapid City architecture firm. Known for place-sensitive design, ARC International delivers solutions that do more with less and feel native to their surroundings. With 27 years serving Rapid City, the team deepens ISG’s commitment to local clients and represents a strategic investment in growing ISG’s architecture team, enhancing the firm’s ability to serve communities across South Dakota.
By ISG · Via GlobeNewswire · April 3, 2026
NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Navan, Inc. (“Navan” or “the Company”) (NASDAQ: NAVN) for violations of the federal securities laws.
By Schall Law · Via GlobeNewswire · April 3, 2026
SNOW Investors Have Opportunity to Lead Snowflake Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Snowflake Inc. (“Snowflake” or “the Company”) (NYSE: SNOW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated (“Corcept” or “the Company”) (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
PYPL Investors Have Opportunity to Lead PayPal Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PayPal Holdings, Inc. (“PayPal” or “the Company”) (NASDAQ: PYPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026
ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enphase Energy, Inc. (“Enphase” or “the Company”) (NASDAQ: ENPH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · April 3, 2026